149 related articles for article (PubMed ID: 9070705)
1. Allogenic leukocyte immunization after five or more miscarriages. Recurrent Miscarriage Immunotherapy Trialists Group.
Carp HJ; Toder V; Torchinsky A; Portuguese S; Lipitz S; Gazit E; Mashiach S
Hum Reprod; 1997 Feb; 12(2):250-5. PubMed ID: 9070705
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of anti-paternal antibodies and leukocyte immunizations on the proportion of live births in couples with consecutive recurrent miscarriages.
Orgad S; Loewenthal R; Gazit E; Sadetzki S; Novikov I; Carp H
Hum Reprod; 1999 Dec; 14(12):2974-9. PubMed ID: 10601081
[TBL] [Abstract][Full Text] [Related]
3. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
Am J Reprod Immunol; 1994 Sep; 32(2):55-72. PubMed ID: 7826502
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
Daya S; Gunby J
Am J Reprod Immunol; 1994 Dec; 32(4):294-302. PubMed ID: 7718097
[TBL] [Abstract][Full Text] [Related]
5. Selection of patients with habitual abortion for paternal leucocyte immunization.
Carp HJ; Toder V; Gazit E; Orgad S; Mashiach S; Serr DM; Nebel L
Arch Gynecol Obstet; 1990; 248(2):93-101. PubMed ID: 2150303
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal-fetal immuno-recognition].
Li D; Li C; Zhu Y
Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):597-600. PubMed ID: 10806684
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing success rate of leukocyte immunization and anti-paternal antibodies in spontaneous recurrent miscarriage.
Chaichian S; Shoaee S; Saremi A; Pedar S; Firouzi F
Am J Reprod Immunol; 2007 Mar; 57(3):169-76. PubMed ID: 17295895
[TBL] [Abstract][Full Text] [Related]
8. IgG anti-laminin-1 autoantibody and recurrent miscarriages.
Inagaki J; Matsuura E; Nomizu M; Sugiura-Ogasawara M; Katano K; Kaihara K; Kobayashi K; Yasuda T; Aoki K
Am J Reprod Immunol; 2001 Apr; 45(4):232-8. PubMed ID: 11327550
[TBL] [Abstract][Full Text] [Related]
9. Neonatal thrombocytopenia induced by maternal anti-HLA antibodies: a potential side effect of allogenic leukocyte immunization for unexplained recurrent aborters.
Tanaka T; Umesaki N; Nishio J; Maeda K; Kawamura T; Araki N; Ogita S
J Reprod Immunol; 2000 Feb; 46(1):51-7. PubMed ID: 10708244
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy and neonatal outcomes in unexplained recurrent/habitual aborters treated by allogenic leukocyte immunization.
Tanaka T; Umesaki N; Maeda K; Miyama M; Ogita S
Osaka City Med J; 1997 Jun; 43(1):81-7. PubMed ID: 9343997
[TBL] [Abstract][Full Text] [Related]
11. Clinical, immunologic, and genetic definitions of primary and secondary recurrent spontaneous abortions.
McIntyre JA; McConnachie PR; Taylor CG; Faulk WP
Fertil Steril; 1984 Dec; 42(6):849-55. PubMed ID: 6594246
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for recurrent miscarriage.
Porter TF; LaCoursiere Y; Scott JR
Cochrane Database Syst Rev; 2006 Apr; (2):CD000112. PubMed ID: 16625529
[TBL] [Abstract][Full Text] [Related]
13. Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization.
Malinowski A; Wilczynski J; Zeman K; Glowacka E; Kolasa D; Szpakowski A; Oszukowski P; Szpakowski M
Zentralbl Gynakol; 1998; 120(10):493-502. PubMed ID: 9823650
[TBL] [Abstract][Full Text] [Related]
14. Immunization by paternal leukocytes for prevention of primary habitual abortion: results of a matched controlled trial.
Carp HJ; Toder V; Gazit E; Orgad S; Mashiach S; Nebel L; Serr DM
Gynecol Obstet Invest; 1990; 29(1):16-21. PubMed ID: 2351331
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of leukocyte immunotherapy in primary recurrent spontaneous abortion (RSA).
Gharesi-Fard B; Zolghadri J; Foroughinia L; Tavazoo F; Samsami Dehaghani A
Iran J Immunol; 2007 Sep; 4(3):173-8. PubMed ID: 17767017
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of research in chronic spontaneous abortion.
McIntyre JA; Faulk WP
Am J Reprod Immunol Microbiol; 1986 Mar; 10(3):121-6. PubMed ID: 2940881
[TBL] [Abstract][Full Text] [Related]
17. Treatment of recurrent aborters by immunization with paternal cells--controlled trial.
Cauchi MN; Lim D; Young DE; Kloss M; Pepperell RJ
Am J Reprod Immunol; 1991 Jan; 25(1):16-7. PubMed ID: 2029327
[TBL] [Abstract][Full Text] [Related]
18. Adverse influence of numbers of previous miscarriages on results of paternal lymphocyte immunization in patients with recurrent spontaneous abortions.
Katano K; Aoki K; Ogasawara MS; Suzumori K
Am J Reprod Immunol; 2000 Nov; 44(5):289-92. PubMed ID: 11125791
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of habitual abortion.
Carp HJ; Toder V; Mashiach S
Am J Reprod Immunol; 1992; 28(3-4):281-4. PubMed ID: 1285902
[TBL] [Abstract][Full Text] [Related]
20. Recurrent miscarriage (REMIS) study: how should data from women who do not become pregnant be handled?
Karrison TG; Ober C
Control Clin Trials; 1998 Oct; 19(5):430-9. PubMed ID: 9741864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
